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Fibroblast growth factor (FGF)-activated signaling regulates an array of cellular processes ranging from
embryonic development to tissue repair. A recent paper by Murakami et al. identifies a potentially important
role for FGF signaling in maintenance of endothelial barrier homeostasis through the regulation of adherens
junctions.
The fibroblast growth factor (FGF) family
comprises 22 members in the human
and mouse with pleiotropic functions
including cell migration, proliferation, dif-
ferentiation, and survival. Many FGF-
mediated signaling events are initiated
through the classic FGF-FGFR axis in
which binding of FGF to high-affinity cell
surface tyrosine kinase receptors (FGFRs)
leads to receptor dimerization and trans-
autophosphorylation (reviewed in Itoh
and Ornitz, 2004). The four FGFRs and
their splice isoforms display different li-
gand-binding specificities, allowing them
to produce differential cellular responses
depending on the context. Although the
role of FGFs in angiogenesis is well
known, the importance of the FGF system
in regulating the endothelial barrier func-
tion of the vessel had not been addressed
until now. In an article in the Journal of
Clinical Investigation, Murakami et al.
(2008) present the first evidence for a crit-
ical role of FGF signaling in maintenance
of vascular integrity due to its ability to
anneal adherens junctions (AJs).
The authors use two complementary
approaches to examine the functional
role of FGF signaling in adult mouse vas-
culature: expression of soluble FGF re-
ceptor traps and a cytoplasmic truncated
form of FGFR1IIIc that acts as a domi-
nant-negative by heterodimerizing with
all other FGFR isoforms. The dominant-
negative approach addresses the overall
role of FGFR signaling, while soluble traps
provide information about the contribution
of individual ligands. The expression of
the dominant-negative receptor caused
loss of endothelial cell-cell adhesion in
both arterial and venous vascular beds.
Systemic expression of the sFGFR1IIIc
and sFGFR3IIIc traps, both of which affect
a wide range of FGF family members, also
resulted in the loss of integrity of tracheal
microvessels, but this was not the case
with the sFGFR3IIIb trap. Based on the li-
gand-binding specificities of these differ-
ent traps, FGF2, FGF4, and FGF8, which
are specific for both FGFR1IIIc and
FGFR3IIIc, appear to be the keymediators
responsible for maintenance of endothe-
lial barrier homeostasis. The question of
whether all three factors are involved
remains to be addressed. FGF2 and
FGF1 are known to induce angiogenesis
in vivo, but neither single nor double
knockout of these factors in mice causes
any defect in vascular development (Miller
et al., 2000), suggesting that other family
members compensate for the absence of
FGF1 and FGF2. By contrast, genetic
deletion of either fgf4 or fgf8 is early em-
bryonic lethal (Feldman et al., 1995; Sun
et al., 1999). A powerful approach for
future studies examining the relative con-
tributions of FGF2, FGF4, and FGF8 to
maintenance of junctional integrity would
be to generate endothelial-specific con-
ditional deletions of the corresponding
genes.
One potential explanation for the ob-
served loss of vascular integrity is that
FGF signaling is required for regulation
of endothelial cell proliferation and sur-
vival. However, the authors ruled this out
by showing that disruption of FGF signal-
ing did not decrease the cell density in en-
dothelial monolayers or induce apoptosis
(Murakami et al., 2008). Instead, their re-
sults suggest that FGF signaling is directly
required for maintenance of interendothe-
lial adhesion. Suppression of FGF signal-
ing led to dissociation of junctional adhe-
sions in both arterial and venous vascular
beds. VE-cadherin-based AJs and clau-
din-based tight junctions (TJs) form
a semipermeable endothelial barrier be-
tween the vessel lumen and stroma. Al-
though both junctions contribute to main-
tenance of tissue fluid homeostasis, AJs
are predominant while TJs are poorly de-
veloped in endothelial barriers (with the
exception being the blood-brain barrier).
In addition, VE-cadherin-mediated adhe-
sion induces the expression of the TJ ad-
hesive molecule claudin-5, and therefore
acts ‘‘upstream’’ of TJs (Taddei et al.,
2008). AJs composed of VE-cadherin,
a-catenin, b-catenin, and p120-catenin
are indispensable in the regulation of
vascular integrity and endothelial barrier
function. The association of p120-catenin
at the VE-cadherin juxtamembrane do-
main is known to inhibit VE-cadherin
internalization by interfering with its bind-
ing to adaptor proteins of the clathrin-me-
diated endocytic pathway (Miyashita and
Ozawa, 2007). Murakami et al. (2008)
found that stimulation of endothelial
monolayers with FGF1 increased p120-
catenin-VE-cadherin interaction, whereas
inhibition of FGF signaling induced un-
coupling of p120-catenin from VE-cad-
herin, leading to VE-cadherin internaliza-
tion. Therefore, the loss of endothelial
barrier integrity in the absence of FGF sig-
naling could be explained by destabiliza-
tion of VE-cadherin homophilic adhesion
and subsequent dissociation of AJs.
What are the signaling mechanisms by
which FGF exerts its effect on AJs? Tak-
ing into account the known functions of
FGF signaling in angiogenesis, one possi-
ble mechanism could involve N-cadherin.
N-cadherin is also expressed in endothe-
lial cells, mediates adhesion between en-
dothelium and pericytes or smooth mus-
cle cells, and functions coordinately with
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VE-cadherin during vascular morphogen-
esis (Luo and Radice, 2005). Because
FGFRs interact directly with N-cadherin
and regulate its function, FGF signaling
might indirectly control stability of VE-
cadherin adhesion, and thereby junctional
integrity. Murakami et al. examined this
possibility, but found that inhibition of
FGF signaling did not affect N-cadherin
cell surface expression or N-cadherin-
mediated adhesion of endothelial cells
to smooth muscle cells. Another model,
favored by Murakami et al., is that FGF
signaling regulates the stability of AJs
by counteracting signals activated by
another angiogenic factor, vascular endo-
thelial growth factor (VEGF). In this model
(Figure 1), VEGF induces Src-dependent
activation of p21-activated kinase (PAK),
which in turn phosphorylates VE-cadherin
on Ser665 and stimulates its b-arrestin-me-
diated endocytosis (Gavard and Gutkind,
2006). Although this hypothesis does not
as yet have experimental support, the con-
cept of such a crosstalk between FGF and
VEGF signaling pathways (Figure 1) is test-
able. Because FGF2 is known to induce
VEGF expression in endothelial cells
through paracrine and autocrine mecha-
nisms (Seghezzi et al., 1998), it is also pos-
sible that inhibition of the FGF system itself
perturbs VEGF signaling.
Although a number of fundamental
questions remain, the study by Murakami
et al. (2008) has uncovered a new role of
FGF signaling and its possible interplay
with VEGF signaling in the maintenance
of endothelial junctions and, thus, vascu-
lar integrity. It is apparent from this study
that unraveling further the details of endo-
thelial barrier function, the most important
function of the endothelium, has a great
deal to teach us about angiogenesis, the
disruption of the barrier in disease states,
and how to restore barrier integrity.
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Figure 1. A Speculative Model for the Role of FGF Signaling in Regulating AJ Integrity through Inhibition of VEGF Signaling
FGF signaling could regulate the integrity of AJs by counteracting VEGF-mediated VE-cadherin internalization. FGF deficiency or increased VEGF production
leads to disruption of AJs and increased endothelial permeability. VEGF-VEGFR2 signaling results in sequential activation of Vav2, Rac1, and PAK in
a Src-dependentmanner. PAK phosphorylates VE-cadherin, leading to dissociation of p120-catenin from VE-cadherin and VE-cadherin internalization. However,
FGF signaling could potentially override this mechanism by inhibiting PAK-mediated phosphorylation of VE-cadherin. p120, p120-catenin; b-cat, b-catenin;
a-cat, a-catenin.
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